13567_2018_530_MOESM6_ESM.docx (13.08 kB)
MOESM6 of In-feed bambermycin medication induces anti-inflammatory effects and prevents parietal cell loss without influencing Helicobacter suis colonization in the stomach of mice
journal contribution
posted on 2018-04-10, 05:00 authored by Chloë De Witte, Bernard Taminiau, Bram Flahou, Veerle Hautekiet, Georges Daube, Richard Ducatelle, Freddy HaesebrouckAdditional file 6. Overview of the relative fold changes of altered markers for gastric acid secretion in the bambermycin-supplemented and non-supplemented groups. The data are presented as fold changes in gene expression normalized to 3 reference genes and relative to control groups 1 and 4 (i.e. group 2-4 relative to group 1 and group 5-6 relative to group 4) which are considered as 1. The fold changes are shown as means with the standard error of the mean. Statistical differences were calculated using the non-parametric Kruskal–Wallis H test SPSS statistics 24®. A P-value lower than 0.05 is considered to be significant. Group 2 = 32 ppm bambermycin supplemented, non-H. suis infected group; group 3 = 64 ppm bambermycin supplemented, non-H. suis infected group; group 4 = H. suis-positive control group without bambermycin supplementation; group 5 = 32 ppm bambermycin supplemented, H. suis infected group; group 6 = 64 ppm bambermycin supplemented, H. suis infected group.
Funding
Huvepharma
History
Usage metrics
Categories
Keywords
suis-positive control group6. Overviewnon-supplemented groupsStatistical differences3 reference genesSPSSIn-feed bambermycin medicationMOESM 6anti-inflammatory effectsgene expressioncontrol groups 1acid secretionHelicobacter suis colonizationbambermycin supplementationgroup 5-6group 2-4parietal cell lossgroup 1
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC